[The effect of cytostatic drugs on blood platelets and lymphocytes in patients with neoplasms].
D000227:Adenine Nucleotides / Q000032:analysis; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000578:Amidines / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D049454:Firefly Luciferin; D005472:Fluorouracil / Q000627:therapeutic use; D006037:Glyoxal / Q000031:analogs & derivatives; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy; D008156:Luciferases; D008214:Lymphocytes / Q000187:drug effects*; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D009391:Nephelometry and Turbidimetry; D010954:Plasmacytoma / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D014748:Vinca Alkaloids / Q000627:therapeutic use
D000227:Adenine Nucleotides; D000578:Amidines; D000903:Antibiotics, Antineoplastic; D006835:Hydrazones; D014748:Vinca Alkaloids; D001761:Bleomycin; D006037:Glyoxal; D049454:Firefly Luciferin; D000244:Adenosine Diphosphate; D004317:Doxorubicin; D003520:Cyclophosphamide; D008156:Luciferases; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate
Zytostatikawirkung auf Thrombozyten und Lymphozyten von Tumorpatienten